| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 60.5% | 26/43 |
| Female | 39.5% | 17/43 |
| Indifferent | 0% | 0/43 |
| Unknown | 0% | 0/43 |
| General | ||
| Birth Length | 0% | 0/43 |
| 7% | 3/43 | |
| 9.3% | 4/43 | |
| 14% | 6/43 | |
| 11.6% | 5/43 | |
| 27.9% | 12/43 | |
| 97.7% | 42/43 | |
| 100% | 43/43 | |
| 86% | 37/43 | |
| 26.8% | 11/41 | |
| Neurology | ||
| 95.3% | 41/43 | |
| 55.8% | 24/43 | |
| 34.9% | 15/43 | |
| Facial abnormalities | ||
| 55.8% | 24/43 | |
| 72.1% | 31/43 | |
| 41.9% | 18/43 | |
| 74.4% | 32/43 | |
| Visual and hearing impairments | ||
| 20.9% | 9/43 | |
| 25.6% | 11/43 | |
| Heart | ||
| 9.3% | 4/43 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/14 |
| Gastrointestinal | ||
| 69.8% | 30/43 | |
| Urogenital | ||
| 14% | 6/43 | |
| Skeleton | ||
| 60.5% | 26/43 | |
| Skin / Hair / Nails | ||
| 44.2% | 19/43 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/43 |
| Metabolic | 0% | 0/43 |
| Immune | 0% | 0/43 |
| Neoplasia | ||
| Neoplasia | 0% | 0/43 |
| Inheritance | ||
| 100% | 42/42 | |
